Your session is about to expire
← Back to Search
Lifestyle Intervention for Cancer Survivors
Study Summary
This trial is testing an intervention to help Hispanic cancer survivors reduce symptoms and adhere to American Cancer Society guidelines for cancer prevention.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am under 18, finished cancer treatment over a year ago, and have a caregiver willing to join.I am a Hispanic female cancer survivor, over 18, with a caregiver, and have had severe cancer symptoms.I am over 18, speak English or Spanish, have a phone, and am not being treated for cancer.I am a caregiver under 18, without phone access, not in diet counseling or cancer treatment.
- Group 1: Symptom management and lifestyle intervention
- Group 2: Attention control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is enrollment for this study taking place at the moment?
"Absolutely. According to information sourced from clinicaltrials.gov, this medical research project is currently enrolling participants; it was first posted on the 25th of August 2022 and has since undergone some revisions. A total of 217 patients are needed at one particular location for participation in the trial."
How many individuals are eligible to take part in this clinical research initiative?
"Absolutely. According to clinicaltrials.gov, this medical investigation is actively recruiting participants as of August 25th 2022 - the same day it was posted and last updated. 217 subjects are required at a single site."
Share this study with friends
Copy Link
Messenger